Literature DB >> 4821443

Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man.

A Breckenridge, M Orme, H Wesseling, R J Lewis, R Gibbons.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4821443     DOI： 10.1002/cpt1974154424

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  63 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Species-dependent stereospecific serum protein binding of the oral anticoagulant drug phenprocoumon.

Authors:  W Schmidt; E Jähnchen
Journal:  Experientia       Date:  1978-10-15

3.  The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans.

Authors:  M A Perera; E Gamazon; L H Cavallari; S R Patel; S Poindexter; R A Kittles; D Nicolae; N J Cox
Journal:  Clin Pharmacol Ther       Date:  2011-01-26       Impact factor: 6.875

Review 4.  Progress in clinical pharmacology over the last 20 years.

Authors:  Michel Eichelbaum
Journal:  Br J Clin Pharmacol       Date:  2003-05       Impact factor: 4.335

Review 5.  Clinical relevance of cimetidine drug interactions.

Authors:  A F Shinn
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

6.  Population pharmacokinetic modelling of S-warfarin to evaluate the design of drug-drug interaction studies for CYP2C9.

Authors:  Kerenaftali Klein; Ivelina Gueorguieva; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-01-21       Impact factor: 2.745

Review 7.  Considerations when prescribing trimethoprim-sulfamethoxazole.

Authors:  Joanne M-W Ho; David N Juurlink
Journal:  CMAJ       Date:  2011-10-11       Impact factor: 8.262

Review 8.  Pharmacogenomic progress in individualized dosing of key drugs for cancer patients.

Authors:  Christine M Walko; Howard McLeod
Journal:  Nat Clin Pract Oncol       Date:  2009-01-27

9.  Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial.

Authors:  Carlo Federico Zambon; Vittorio Pengo; Stefania Moz; Dania Bozzato; Paola Fogar; Andrea Padoan; Mario Plebani; Francesca Groppa; Giovanni De Rosa; Roberto Padrini
Journal:  Eur J Clin Pharmacol       Date:  2018-02-02       Impact factor: 2.953

10.  Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.

Authors:  Xuemin Jiang; Kenneth M Williams; Winston S Liauw; Alaina J Ammit; Basil D Roufogalis; Colin C Duke; Richard O Day; Andrew J McLachlan
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.